FDA Issues Safety Alert on Weight-Loss Drug's Kidney Risks

(MedPage Today) -- The FDA issued a drug safety communication approving a label change that warns about the risk of kidney stones or kidney injury with the over-the-counter (OTC) weight loss drug orlistat (alli), the agency said Wednesday.
The...